Haddadin Yezan Munther — SEC Form 4 filings

SEC reporting owner CIK 1718004. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-03.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-08 to 2026-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Outlook Therapeutics, Inc. (OTLK)Director63 legs · 64,882 sh · $61,3476

Form 4 filings — Haddadin Yezan Munther

FiledFormIssuerReported transactionsSource
2026-06-034Outlook Therapeutics, Inc. (OTLK)Purchase (P): 29,000 @ $0.83EDGAR
2026-05-274Outlook Therapeutics, Inc. (OTLK)Purchase (P): 34,000 @ $0.44EDGAR
2025-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 95,969 (derivative) @ $0EDGAR
2024-10-034Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 56,636 (derivative) @ $0 · Grant/award (A): 132,293 (derivative) @ $0 · Grant/award (A): 19,771 (derivative) @ $0EDGAR
2024-03-294Outlook Therapeutics, Inc. (OTLK)Purchase (P): 1,881.71 @ $11.82EDGAR
2024-03-084Outlook Therapeutics, Inc. (OTLK)Grant/award (A): 94,441 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1718004 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →